Investidor Profissional Gestao de Recursos Ltda. Grows Holdings in HCA Healthcare, Inc. $HCA

Investidor Profissional Gestao de Recursos Ltda. raised its position in HCA Healthcare, Inc. (NYSE:HCA) by 52.2% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 6,867 shares of the company’s stock after acquiring an additional 2,354 shares during the quarter. HCA Healthcare comprises approximately 1.3% of Investidor Profissional Gestao de Recursos Ltda.’s holdings, making the stock its 12th largest position. Investidor Profissional Gestao de Recursos Ltda.’s holdings in HCA Healthcare were worth $2,631,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Cheviot Value Management LLC acquired a new stake in shares of HCA Healthcare in the 1st quarter valued at $26,000. Saudi Central Bank acquired a new position in shares of HCA Healthcare during the 1st quarter worth about $26,000. WPG Advisers LLC acquired a new stake in HCA Healthcare during the 1st quarter worth $27,000. Ameriflex Group Inc. purchased a new stake in HCA Healthcare in the 2nd quarter valued at $27,000. Finally, Chung Wu Investment Group LLC acquired a new stake in shares of HCA Healthcare during the second quarter worth $27,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Activity

In other news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares of the company’s stock, valued at $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the sale, the executive vice president owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their position. The SEC filing for this sale provides additional information. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Stock Up 0.3%

Shares of HCA Healthcare stock opened at $478.64 on Wednesday. The business has a fifty day simple moving average of $436.04 and a 200-day simple moving average of $398.67. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $480.00. The firm has a market cap of $109.22 billion, a price-to-earnings ratio of 18.50, a price-to-earnings-growth ratio of 1.38 and a beta of 1.41.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. During the same quarter in the previous year, the company posted $4.90 EPS. The business’s revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be issued a $0.72 dividend. The ex-dividend date is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio is presently 11.13%.

Wall Street Analysts Forecast Growth

A number of research firms have commented on HCA. Morgan Stanley set a $425.00 target price on HCA Healthcare in a research report on Monday, October 27th. Jefferies Financial Group boosted their price objective on shares of HCA Healthcare from $485.00 to $525.00 and gave the company a “buy” rating in a research report on Tuesday, October 28th. Sanford C. Bernstein reiterated a “market perform” rating and issued a $417.00 price target on shares of HCA Healthcare in a report on Monday, October 27th. Mizuho increased their target price on shares of HCA Healthcare from $475.00 to $505.00 and gave the stock an “outperform” rating in a research report on Monday, October 27th. Finally, Barclays upped their target price on HCA Healthcare from $445.00 to $494.00 and gave the stock an “overweight” rating in a research report on Monday, October 27th. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and ten have issued a Hold rating to the company. According to MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $474.53.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.